25th Feb 2026 How the body handles lower-dose nilotinib tablet (Danziten™) versus capsule (Tasigna®): a plain language summary
22nd Jan 2025 Plain language summary of the ASCEMBL study: comparing asciminib and bosutinib after multiple prior treatments for chronic myeloid leukemia